|
|
|
|
|
|
|
|
|
Monday June 27, 2005
|
|
11:30 am
|
|
|
12:15 pm
|
|
| |
Richard J. Martin M.D.
Acting Chairman, Department of Medicine
Head, Pulmonary Division
National Jewish Medical and Research Center
Edelstein Family Chair in Pulmonary Medicine
Professor of Medicine
National Jewish Medical and Research Center
University of Colorado Health Sciences Center
|
|
|
|
|
12:30 pm
|
- Discuss the costs of respiratory health to the nation
- How does government influence research and economic direction of respiratory disease?
- What are some of the best practice initiatives in respiratory health?
- Examine prevention incentives to encourage the delivery of cost-effective respiratory disease services
|
| Moderator/Panelist: |
|
| |
Peter Almenoff MD, FCCP
National Program Director
Pulmonary/Critical Care
Veterans Health Administration
|
| Panelists |
|
| |
Dennis Doherty MD, FCCP
Professor of Medicine
Chief, Division of Pulmonary and Critical Care Medicine
Medical Director, Respiratory Care Services
University of Kentucky Chandler Medical Center
Lexington Veteran’s Administration Center
Chair, National Lung Health Education Program
|
| |
Peter J. Gergen M.D.,M.P.H.
Senior Medical Officer
National Institute of Health/Asthma, Allergy and Inflammation Branch, Division of Allergy, Immunology and Transplantation
|
| |
Corinne Husten MD, MPH
Acting Director
Office of Smoking and Health
Centers for Disease Control
 View Biography
|
|
|
|
1:30 pm
|
| Construct a preventive model to reduce beryllium disease in the workplace
Develop a process to improve company capability to manage safety
Identify and manage safety and causative factors, the leading measures, to produces safety results, the lagging measures
Demonstrate the cost of prevention is lower than the social, medical and legal expenses |
| |
David C. Deubner MD MPH
Vice President Occupational and Environmental Medicine
Corporate Medical Director
Brush Wellman
View Biography
|
|
|
|
|
2:30 pm
|
|
|
3:00 pm
|
| Discuss the impact of respiratory disease to American businesses
Demonstrate a range of respiratory disease programs in use by payors to reduce the incidence of asthma, COPD and allergies
Discuss results in productivity, effectiveness and reduced health care costs |
|
|
|
|
4:00 pm
|
- Discuss treatments for pulmonary disease in the era of rising health care costs
- Which treatments meet safety and clinical efficacy and are effective and efficient?
- Demonstrate practices that have economic impact
|
| Moderator/Panelist: |
|
| |
Richard O’Connor MD
Medical Director
Department of Quality Management
Sharp Rees-Stealy Medical Group
View Biography
|
| Panelists: |
|
| |
Aidan A Long MD FRCP(C)
Clinical Director of Allergy
Training Program Director in Allergy and Clinical Immunology
Massachusetts General Hospital
Assistant Professor of Medicine
Harvard Medical School
|
| |
Jonathan Weissler MD, FCCP
Professor of Internal Medicine
Chief, Division of Pulmonary and Critical Care Medicine
University of Texas Southwestern Medical Center
|
|
|
|
5:00 pm
|
|
|
|
|
|
|
|
|
|
|